Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract.
Sarbia
Mario
M
Institute of Pathology, Technical University, Munich, Germany. mario.sarbia@lrz.tu-muenchen.de
Geddert
Helene
H
Kiel
Sybille
S
Kandemin
Yasemin
Y
Schulz
Wolfgang A
WA
Vossen
Sandra
S
Zotz
Rainer D
RD
Willers
Reinhart
R
Baldus
Stephan E
SE
Schneider
Paul M
PM
Gabbert
Helmut E
HE
D000230:Adenocarcinoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D016022:Case-Control Studies; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D011110:Polymorphism, Genetic; D011379:Prognosis; D012016:Reference Values; D012680:Sensitivity and Specificity; D013274:Stomach Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology
D042965:Methylenetetrahydrofolate Reductase (NADPH2)